Fierce Pharma

JULY 16, 2024

Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act. | Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act.

272

272

Copyright Clearance Center

JULY 16, 2024

July 16, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced the availability of artificial intelligence (AI) re-use rights within its Annual Copyright License s (ACL), an enterprise-wide content licensing solution offering rights from millions of works to businesses that subscribe.

Education 134

Education Ethics Government Media 134

Fierce Pharma

JULY 16, 2024

As Johnson & Johnson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds | As Johnson & Johson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds of millions of dollars to settle a longstanding dispute with a clutch of suppliers.

239

239

MedCity News

JULY 16, 2024

Novo Holdings led Asceneuron’s $100 million Series C financing. The Merck Serono spinout’s lead program is an oral small molecule designed to prevent aggregation of tau protein in neurodegenerative disorders. The post Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial appeared first on MedCity News.

Leads 113

Leads Biopharma Pharma 113

Advertisement

Fierce Pharma

JULY 16, 2024

With several launches underway and partnerships driving sales growth, Sobi is gaining momentum in its quest to become a force in hematology. | The Swedish drugmaker reported 13% sales growth in its hematology portfolio, which includes brands such as Doptelet, Vonjo and Apellis-partnered Empaveli (or Aspaveli in Europe, which is one of Sobi's territories).

Sales 223

Sales 223

MedCity News

JULY 16, 2024

For the past two years, Intermountain Health has been planning to move its hospital in the Denver suburb of Wheat Ridge, Colorado about three and a half miles away to a new and updated facility. The health system is planning to complete the move in one day, using about 20 ambulances to move an estimated 180 patients. The post What Does It Take to Move an Entire Hospital in 1 Day?

Patients 107

Patients 107

MedCity News

JULY 16, 2024

As the clinical trial landscape evolves, prioritizing inclusion, innovation, and scalability is essential for accelerating the development of safe and effective treatments that truly meet the needs of diverse patient populations. The post The Triad of Inclusivity, Innovation, and Scalability: Imperatives for Today’s Clinical Trial Teams appeared first on MedCity News.

Patients 102

Patients FDA 102

Copyright Clearance Center

JULY 16, 2024

Copyright Clearance Center has launched a collective licensing solution for the internal use of copyrighted materials in artificial intelligence systems, with the aim of providing streamlined, legal means to use content and compensate creators.

98

98

MedCity News

JULY 16, 2024

Seven Starling’s Series A funding round was led by RH Capital and included participation from Pear VC, Expa and Magnify Ventures. In total, the company has raised $14.3 million. The post Seven Starling Secures $10.9M To Improve Access to Women’s Mental Health appeared first on MedCity News.

102

102

PharmaVoice

JULY 16, 2024

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

Pharma 105

Pharma Marketing 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

JULY 16, 2024

As the consent landscape continues to evolve, pediatricians are tasked with striking a careful balance – respecting the autonomy of their teenage patients while still operating within the guardrails of state regulations and parental authority. The post The Consent Conundrum Pediatricians Face appeared first on MedCity News.

Patients 90

Patients Physicians 90

pharmaphorum

JULY 16, 2024

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).

Manufacturing 86

Manufacturing 86

Pharmaceutical Technology

JULY 16, 2024

AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.

Pharma 103

Pharma 103

pharmaphorum

JULY 16, 2024

Novo Holdings leads $100m financing for Swiss biotech Asceneuron, which is developing an oral tau therapy for Alzheimer's disease

Leads 100

Leads 100

Advertisement

Distribution

Pharmaceutical Technology

JULY 16, 2024

Kyverna’s CEO Peter Maag said the biotech is “eager to start generating data” from a Phase II trial.

98

98

pharmaphorum

JULY 16, 2024

A digital diagnostic for ADHD called QbTest should be used by the NHS as an add-on to standard assessment, says new NICE guidance

95

95

Pharmaceutical Technology

JULY 16, 2024

As the EU anticipates GLP-1RA shortages throughout 2024, Corden Pharma has pledged $980m to increase manufacturing capacity.

Manufacturing 86

Manufacturing Pharma 86

PharmaTimes

JULY 16, 2024

The progressive neurodegenerative condition affects around 153,000 people in the UK

102

102

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

pharmaphorum

JULY 16, 2024

Natural killer cell therapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m

86

86

PharmaTimes

JULY 16, 2024

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK

Leads 85

Leads 85

Clarivate

JULY 16, 2024

We introduce new data and insights to measure the global research and innovation performance of member countries and regions ahead of the G20 summit in Rio de Janeiro, Brazil. This guide explores how our online interactive scorecard offers dynamic visualizations and insights into global trends. Each year, the Institute for Scientific Information (ISI) at Clarivate releases its annual G20 scorecard to offer insights into the broad contributions of the research and innovation capabilities of each

Leads 59

Leads Engineering Government Management 59

PharmaVoice

JULY 16, 2024

The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

59

59

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Scott’s Directories

JULY 16, 2024

Engaging with medical professionals is a critical aspect of business success in the healthcare sector. In New Brunswick, healthcare providers range from general practitioners to specialized surgeons, creating diverse opportunities for collaboration. This guide explores effective strategies for engaging with these professionals, utilizing resources like the New Brunswick doctors directory to foster meaningful connections.

Medical 52

Medical Doctors Healthcare Provider Networking 52

Contrarian Sales Techniques

JULY 16, 2024

Alex was a medical sales rep, a purveyor of hope in sleekly designed packaging. His product, a revolutionary new stent, was a marvel of engineering, a tiny titanium miracle worker. But Alex knew that dazzling doctors with technical specifications was like trying to seduce a fish with a fishing rod. What really sold was understanding the unspoken needs of the cardiac surgeon, the late-night anxieties in the emergency room, the weight of life and death hanging in the balance.

Doctors 52

Doctors Sales Consulting Medical sales reps 52

PharmaTech

JULY 16, 2024

The event will explore new technologies such as AI, digital twins, development approaches, CMC strategies, and regulatory frameworks, supporting rapid access to vaccines and biotherapeutics.

52

52

Vodori

JULY 16, 2024

Unveiling the complexity of pharma commercial ecosystems The pharmaceutical industry is a complex and dynamic field where innovation, regulation, and market needs intersect. At the heart of this industry lies the commercial ecosystem, a multifaceted network of internal and external stakeholders, processes , and technologies working in unison to bring therapeutic solutions from conception to the patient.

Pharma 52

Pharma Networking Pharmaceutical Marketing 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

pharmaphorum

JULY 16, 2024

Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world. In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potential eye drop treatment for diabetic retinopathy and diabetic macular oedema, instead of invasive injections into the eye.

Healthcare 52

Healthcare Healthcare 52

PharmExec

JULY 16, 2024

In this part of his Pharmaceutical Executive video interview, Fabrice Chouraqui, CEO of Cellarity, speaks about the broader implications of Cellarity's approach for the drug discovery field.

Pharmaceutical 52

Pharmaceutical 52

Pharmatutor

JULY 16, 2024

A Comprehensive Review on plant Sida cordifolia L. including its phyto-chemical status and pharmacological properties admin Tue, 07/16/2024 - 15:09 ABOUT AUTHOR Devansh Mehta 1* Author : M.Pharmacy in Pharmacology, M.B.A. in Pharmaceutical Marketing and Hospital Administration, B.Pharmacy. Founding Medical Writing Director, TRM Writer’s LLP Address: Flat No. 301, Third Floor, Eden Garden Housing Complex, Bypass Road, Modipuram, Meerut.

Pharmacology 52

Pharmacology Medical Pharmaceutical Marketing 52

Pharmaceutical Commerce

JULY 16, 2024

The latest news for pharma industry insiders.

Pharma 96

Pharma 96

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization